We want to emphasize the similarities and differences in response to NT‐3 gene therapy between the accelerated sarcopenia model resulting from underlying increased oxidative stress/mitochondria dysfunction in SOD1KO mice at 1 year of age and the naturally occurring sarcopenia model, Bl6 mice at 2 years of age. This evidence concerns the gene NTF3 and sarcopenia.